Ocean Biomedical, Inc. (OCEA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US67644C1045
Ocean Biomedical, Inc. financials
| Fiscal year | 2024 |
|---|---|
| Operating income | -3.80 m USD |
| EBIT | -9.48 m USD |
| Net income | -9.48 m USD |
| Diluted EPS – continuing operations | -0.34 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ocean Biomedical, Inc.
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company's infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.
More stocks
- C2 Blockchain, Inc. (CBLO)
- Artificial Intelligence Technology Solutions Inc. (AITX)
- Sparx Holdings Group, Inc. (SHGI)
- LINGERIE FIGHTING CHAMPIONSHIPS, INC. (BOTY)
- AI Era Corp. (AERA)
- SCWorx Corp. (WORX)
- Nuburu, Inc. (BURU)
- FiscalNote Holdings, Inc. (NOTE)
- PAION (PA8.SG) (PA8.SG)
- One World Products, Inc. (OWPC)
- Rani Therapeutics Holdings, Inc. (RANI)
- Regen BioPharma Inc (RGBPP)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.